Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04252573 · ClinicalTrials.gov registry record · NA
Chimney EndoVascular Aneurysm Sealing Of New Expanded Indication
A NA study of 1 Paravisceral Abdominal Aortic Aneurysm and 2 Juxtarenal Abdominal Aortic Aneurysm, sponsored by Endologix.
- Active
- Registry status
- NA
- Development phase
- 13
- Enrollment target
- 8
- Study locations
NCT04252573: Active NA study of 1 Paravisceral Abdominal Aortic Aneurysm and 2 Juxtarenal Abdominal Aortic Aneurysm, sponsored by Endologix.
NCT04252573 is a NA study of 1 Paravisceral Abdominal Aortic Aneurysm and 2 Juxtarenal Abdominal Aortic Aneurysm that is active but no longer recruiting, run by Endologix. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 8 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04252573, a NA study of 1 Paravisceral Abdominal Aortic Aneurysm and 2 Juxtarenal Abdominal Aortic Aneurysm, is active but no longer recruiting, sponsored by Endologix.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
- 8
- Study locations
Study Summary
Prospective, multi-center, non-randomized study with consecutive, eligible subject enrollment at each site, for the evaluation of the ChEVAS System for Endovascular Repair of Complex Abdominal Aortic Aneurysms.
Primary Outcome
The outcome at one-month post index procedure will be measured by the proportion of subjects that experience technical success and the absence of severe bowel ischemia, permanent paraplegia/paraparesis, renal failure, disabling stroke, abdominal aortic aneurysm rupture, and aneurysm-related mortality within 30-days of the index procedure.
Conditions Studied
Interventions
- DEVICE Chimney Endovascular Aortic Sealing (ChEVAS) System
Study Locations (8)
Alabama
- Valley Vascular Consultants - Huntsville
District of Columbia
- MedStar Health Research Institute - Washington D.C.
Georgia
- Emory University - Atlanta
Indiana
- St Vincent Medical Group - Indianapolis
Missouri
- University of Missouri - Columbia
New Jersey
- Cooper University Hospital - Camden
New York
- Icahn School of Medicine at Mount Sinai - New York
Oregon
- Providence Portland - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2020-06-29 |
| Est. Completion | 2028-03 |
| Phase | NA |
What the registry record for NCT04252573 still lists
NCT04252573 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 4 conditions, with 1 Paravisceral Abdominal Aortic Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Chimney Endovascular Aortic Sealing (ChEVAS) System is the first listed.
NCT04252573 lists 8 locations in 8 states (Alabama, District of Columbia, Georgia).
Frequently Asked Questions
What is clinical trial NCT04252573 about?
NCT04252573 is a clinical study titled "Chimney EndoVascular Aneurysm Sealing Of New Expanded Indication". Prospective, multi-center, non-randomized study with consecutive, eligible subject enrollment at each site, for the evaluation of the ChEVAS System for Endovascular Repair of Complex Abdominal Aortic Aneurysms.
What is the current status of trial NCT04252573?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 13 participants. The study started on 2020-06-29. Estimated completion is 2028-03.
What conditions does trial NCT04252573 study?
This clinical trial studies the following conditions: 1 Paravisceral Abdominal Aortic Aneurysm, 2 Juxtarenal Abdominal Aortic Aneurysm, 3 Pararenal Abdominal Aortic Aneurysm, 4 Complex Abdominal Aortic Aneurysms.
What interventions are being tested in trial NCT04252573?
The interventions under investigation include: Chimney Endovascular Aortic Sealing (ChEVAS) System (DEVICE).
Who is sponsoring clinical trial NCT04252573?
This trial is sponsored by Endologix, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04252573 being conducted?
This trial has 8 study locations across Alabama, District of Columbia, Georgia, Indiana, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04252573's enrollment target sits among peer trials
13 1911th of 2000 higher than 88 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI